Search

Author/Creator Sultan, Keith

4. Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes. Issue 11 (18th October 2019)

Authors:
Koliani-Pace, Jenna L; Singh, Siddharth; Luo, Michelle; Hirten, Robert; Aniwan, Satimai; Kochhar, Gursimran; Chang, Shannon; Lukin, Dana; Gao, Youran; Bohm, Matthew; Swaminath, Arun; Gupta, Nitin; Shmidt, Eugenia; Meserve, Joseph; Winters, Adam; Chablaney, Shreya; Faleck, David M; Yang, Jiao; Hua...
Journal:
Inflammatory bowel diseases
Issue:
Volume 25:Issue 11(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes. Issue 11 (3rd May 2019)

Authors:
Koliani-Pace, Jenna L; Singh, Siddharth; Luo, Michelle; Hirten, Robert; Aniwan, Satimai; Kochhar, Gursimran; Chang, Shannon; Lukin, Dana; Gao, Youran; Bohm, Matthew; Swaminath, Arun; Gupta, Nitin; Shmidt, Eugenia; Meserve, Joseph; Winters, Adam; Chablaney, Shreya; Faleck, David M; Yang, Jiao; Hua...
Journal:
Inflammatory bowel diseases
Issue:
Volume 25:Issue 11(2019)
Page Start:
1854
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Correction: Vedolizumab for Ulcerative Colitis. (April 2019)

Authors:
Narula, Neeraj; Peerani, Farhad; Meserve, Joseph; Kochhar, Gursimran; Chaudrey, Khadija; Hartke, Justin; Chilukuri, Prianka; Koliani-Pace, Jenna; Winters, Adam; Katta, Leah; Shmidt, Eugenia; Hirten, Robert; Faleck, David; Parikh, Malav P.; Whitehead, Diana; Boland, Brigid S.; Singh, Siddharth; Sa...
Journal:
American journal of gastroenterology
Issue:
Volume 114:Number 4(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case–control study. (November 2022)

Authors:
Hong, Simon J.; Bhattacharya, Sumona; Aboubakr, Aiya; Nadkarni, Devika; Lech, Diana; Ungaro, Ryan C.; Agrawal, Manasi; Hirten, Robert P.; Greywoode, Ruby; Mone, Anjali; Chang, Shannon; Hudesman, David P.; Ullman, Thomas; Sultan, Keith; Lukin, Dana J.; Colombel, Jean-Frederic; Axelrad, Jordan E.
Journal:
Therapeutic advances in gastroenterology
Issue:
Volume 15(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio‐economic factors. Issue 5 (20th January 2019)

Authors:
Agrawal, Manasi; Cohen‐Mekelburg, Shirley; Kayal, Maia; Axelrad, Jordan; Galati, Jonathan; Tricomi, Brad; Kamal, Kanika; Faye, Adam S.; Abrudescu, Paul; Scherl, Ellen; Lawlor, Garrett; Sultan, Keith; Lukin, Dana; Colombel, Jean‐Frederic; Ungaro, Ryan C.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 49:Issue 5(2019)
Page Start:
564
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. (February 2022)

Authors:
Peyrin-Biroulet, Laurent; Hart, Ailsa; Bossuyt, Peter; Long, Millie; Allez, Matthieu; Juillerat, Pascal; Armuzzi, Alessandro; Loftus, Edward V; Ostad-Saffari, Elham; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Pulley, Jennifer; Lacey, Stuart; Sandborn, William J; Aguilar, Humberto; Ah...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 2(2022)
Page Start:
128
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. (January 2022)

Authors:
Rubin, David T; Dotan, Iris; DuVall, Aaron; Bouhnik, Yoram; Radford-Smith, Graham; Higgins, Peter D R; Mishkin, Daniel S; Arrisi, Pablo; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Lacey, Stuart; McBride, Jacqueline; Panés, Julian; Abdulkhakov, Rustem; Abu ...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 1(2022)
Page Start:
17
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗